Page last updated: 2024-08-25

rosiglitazone and Cystadenocarcinoma, Serous

rosiglitazone has been researched along with Cystadenocarcinoma, Serous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Peng, ZL; Ren, QC; Tan, X	1

Other Studies

1 other study(ies) available for rosiglitazone and Cystadenocarcinoma, Serous

Article	Year
[Proliferation and apoptosis effect of rosiglitazone on human ovarian cancer cell line SKOV3]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2009, Volume: 40, Issue:2 Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cystadenocarcinoma, Serous; Female; Humans; Ovarian Neoplasms; PPAR gamma; Proto-Oncogene Proteins c-myc; RNA, Messenger; Rosiglitazone; Thiazolidinediones	2009

Article

Year

[Proliferation and apoptosis effect of rosiglitazone on human ovarian cancer cell line SKOV3].

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2009, Volume: 40, Issue:2

Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cystadenocarcinoma, Serous; Female; Humans; Ovarian Neoplasms; PPAR gamma; Proto-Oncogene Proteins c-myc; RNA, Messenger; Rosiglitazone; Thiazolidinediones

2009